🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07201246
Starting soon Observational

Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy

NCT07201246 · tracked via the Priya Life Science China tracker
Sponsor
West China Hospital
Phase
Observational
Started
2025-10-05
Last updated
2025-10-01

Condition(s) studied

Necrotizing Pancreatitis

Investigational drug(s) / intervention(s)

Necrotizing Pancreatitis patients' organdysfunction progression

Necrotizing Pancreatitis patients' organdysfunction progression: Study the dynamic nature of organ dysfunction

Study summary

The purpose of this retrospective study was to characterize the changes in organ dysfunction among patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Patients 18 years or older 2. Diagnosis of Acute pancreatitis according to the revised Atlanta classification, requires two of thefollowing three criteria: (A) typical abdominal pain, (B) an increase in serum amylase or lipaselevels higher than three times the upper limit of normality, and (C) signs of AP in imaging3)Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis werescheduled for open necrosectomy 3. Meet Sepsis-3 criteria Exclusion Criteria: Patients undergo repeat surgery on the same site

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West China Hospital, Sichuan University Chengdu China

More West China Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07201246 on ClinicalTrials.gov ↗ ← All trials in China